72 related articles for article (PubMed ID: 14558008)
1. Prolonged survival of heart allografts transduced with AAV-CTLA4Ig.
Chen Z; Lu L; Li J; Xiao X; Fung JJ; Qian S
Microsurgery; 2003; 23(5):489-93. PubMed ID: 14558008
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
Fernandes JR; Duvivier-Kali VF; Keegan M; Hollister-Lock J; Omer A; Su S; Bonner-Weir S; Feng S; Lee JS; Mulligan RC; Weir GC
Transpl Immunol; 2004 Nov; 13(3):191-200. PubMed ID: 15381202
[TBL] [Abstract][Full Text] [Related]
3. Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors.
Maeda Y; Ikeda U; Shimpo M; Ueno S; Ogasawara Y; Urabe M; Kume A; Takizawa T; Saito T; Colosi P; Kurtzman G; Shimada K; Ozawa K
J Mol Cell Cardiol; 1998 Jul; 30(7):1341-8. PubMed ID: 9710802
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival.
Huang BJ; Yin H; Huang YF; Xu JF; Xiong P; Feng W; Zheng F; Xu Y; Fang M; Gong FL
Transpl Immunol; 2006 Aug; 16(2):88-94. PubMed ID: 16860710
[TBL] [Abstract][Full Text] [Related]
5. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
Chen Z; Lu L; Zhang H; Dean NM; Fung JJ; Qian S
Microsurgery; 2003; 23(5):494-7. PubMed ID: 14558009
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
7. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
Yang Z; Rostami S; Koeberlein B; Barker CF; Naji A
Transplantation; 1999 Jun; 67(12):1517-23. PubMed ID: 10401757
[TBL] [Abstract][Full Text] [Related]
8. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
9. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene.
Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Tamura A; Suzuki K; Amemiya H; Hayashi S; Kazui T; Suzuki S
Transplantation; 1999 Sep; 68(6):758-66. PubMed ID: 10515375
[TBL] [Abstract][Full Text] [Related]
10. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
11. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration.
Bostick B; Ghosh A; Yue Y; Long C; Duan D
Gene Ther; 2007 Nov; 14(22):1605-9. PubMed ID: 17898796
[TBL] [Abstract][Full Text] [Related]
12. In vivo high-efficiency transcoronary gene delivery and Cre-LoxP gene switching in the adult mouse heart.
Iwatate M; Gu Y; Dieterle T; Iwanaga Y; Peterson KL; Hoshijima M; Chien KR; Ross J
Gene Ther; 2003 Oct; 10(21):1814-20. PubMed ID: 12960971
[TBL] [Abstract][Full Text] [Related]
13. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy.
Nykänen AI; Pajusola K; Krebs R; Keränen MA; Raisky O; Koskinen PK; Alitalo K; Lemström KB
Circ Res; 2006 Jun; 98(11):1373-80. PubMed ID: 16690881
[TBL] [Abstract][Full Text] [Related]
14. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene transfer of CTLA4Ig gene results in prolonged survival of heart allograft.
Hayashi S; Guang-Lin M; Yokoyama I; Namii Y; Hamada H; Nakao A
Transpl Int; 2000; 13 Suppl 1():S329-32. PubMed ID: 11112025
[TBL] [Abstract][Full Text] [Related]
16. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection.
Laurence JM; Wang C; Zheng M; Cunningham S; Earl J; Tay SS; Allen RD; McCaughan GW; Alexander IE; Bishop GA; Sharland AF
Liver Transpl; 2009 Feb; 15(2):233-41. PubMed ID: 19177450
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats.
Müller OJ; Schinkel S; Kleinschmidt JA; Katus HA; Bekeredjian R
Gene Ther; 2008 Dec; 15(23):1558-65. PubMed ID: 18615116
[TBL] [Abstract][Full Text] [Related]
19. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
[TBL] [Abstract][Full Text] [Related]
20. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
